{"transactions":[{"id":817448,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-04-03T20:38:47.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":false,"shares":140498,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":280998,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":140498},"source":{"system":"sec-edgar","filing":"0001628280-26-023689","document":"wk-form4_1775248724.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026023689/wk-form4_1775248724.xml","form_type":"4"}},{"id":817447,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:38:47.000Z","date":"2026-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":45453,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":133111,"source":{"system":"sec-edgar","filing":"0001628280-26-023689","document":"wk-form4_1775248724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026023689/wk-form4_1775248724.xml","form_type":"4"}},{"id":817446,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:38:47.000Z","date":"2026-04-01","kind":"exercise","planned":false,"acquired":true,"shares":140498,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":178564,"source":{"system":"sec-edgar","filing":"0001628280-26-023689","document":"wk-form4_1775248724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026023689/wk-form4_1775248724.xml","form_type":"4"}},{"id":870085,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-03-03T23:15:47.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":406918,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On March 1, 2026, Mr. Zook was granted 406,918 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":406918,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":406918},"source":{"system":"sec-edgar","filing":"0001628280-26-014146","document":"wk-form4_1772579744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026014146/wk-form4_1772579744.xml","form_type":"4"}},{"id":870084,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-03-03T23:15:47.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":675676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on February 27, 2026 and multiplied by 110%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On March 1, 2026, Mr. Zook was granted 675,676 stock options. The options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":675676,"derivative":{"exercise_price":10.81,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":675676},"source":{"system":"sec-edgar","filing":"0001628280-26-014146","document":"wk-form4_1772579744.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828026014146/wk-form4_1772579744.xml","form_type":"4"}},{"id":1044135,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T21:00:51.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":109847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":109847,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":109847},"source":{"system":"sec-edgar","filing":"0001213900-25-086588","document":"marketforms-70725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086588/marketforms-70725.xml","form_type":"4"}},{"id":1073328,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-08-06T20:07:25.000Z","date":"2025-08-06","kind":"purchase","planned":false,"acquired":true,"shares":17900,"price":5.584,"value":99953.6,"ownership":{"direct":true},"balance_after":38066,"source":{"system":"sec-edgar","filing":"0001628280-25-038322","document":"wk-form4_1754510840.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000162828025038322/wk-form4_1754510840.xml","form_type":"4"}},{"id":1125963,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-06-03T20:06:43.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":false,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-25-000123","document":"wk-form4_1748981195.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000123/wk-form4_1748981195.xml","form_type":"4"}},{"id":1125962,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:43.000Z","date":"2025-06-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":3424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares surrendered to NeoGenomics, Inc. for retirement to satisfy the tax obligations in connection with the December 1, 2024 vesting of restricted stock."}],"balance_after":20166,"source":{"system":"sec-edgar","filing":"0001077183-25-000123","document":"wk-form4_1748981195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000123/wk-form4_1748981195.xml","form_type":"4"}},{"id":1125961,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-06-03T20:06:43.000Z","date":"2025-06-01","kind":"exercise","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":23590,"source":{"system":"sec-edgar","filing":"0001077183-25-000123","document":"wk-form4_1748981195.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000123/wk-form4_1748981195.xml","form_type":"4"}},{"id":1155358,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-05-08T20:13:18.000Z","date":"2025-05-06","kind":"purchase","planned":false,"acquired":true,"shares":18900,"price":7.8793,"value":148918.77,"ownership":{"direct":false,"nature":"Amended and Restated Anthony P. Zook Living Trust"},"balance_after":18900,"source":{"system":"sec-edgar","filing":"0001077183-25-000096","document":"wk-form4_1746735191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000096/wk-form4_1746735191.xml","form_type":"4"}},{"id":1180648,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-04-03T20:06:56.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":421496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On April 1, 2025, Mr. Zook was granted 421,496 restricted stock units. These restricted stock units vest ratably over the first three anniversary dates of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":421496,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":421496},"source":{"system":"sec-edgar","filing":"0001077183-25-000058","document":"wk-form4_1743710801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000058/wk-form4_1743710801.xml","form_type":"4"}},{"id":1180647,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option  (Right to Buy)","published_at":"2025-04-03T20:06:56.000Z","date":"2025-04-01","kind":"grant","planned":false,"acquired":true,"shares":729927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This stock option was granted as a premium-price stock option. To calculate the premium exercise price we used the closing price on April 1, 2025 and multiplied by 110%."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On April 1, 2025, Mr. Zook was granted 729,927 stock options. These options vest ratably over the first three anniversary dates of the grant date."}],"balance_after":729927,"derivative":{"exercise_price":10.44,"expiration_date":"2035-04-01","underlying":"Common Stock","underlying_shares":729927},"source":{"system":"sec-edgar","filing":"0001077183-25-000058","document":"wk-form4_1743710801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718325000058/wk-form4_1743710801.xml","form_type":"4"}},{"id":1435191,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-08-13T20:40:44.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":false,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-24-000137","document":"wk-form4_1723581604.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000137/wk-form4_1723581604.xml","form_type":"4"}},{"id":1435190,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-13T20:40:44.000Z","date":"2024-08-10","kind":"exercise","planned":false,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects release of restricted stock units that were previously reported on a Form 4."}],"balance_after":11336,"source":{"system":"sec-edgar","filing":"0001077183-24-000137","document":"wk-form4_1723581604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000137/wk-form4_1723581604.xml","form_type":"4"}},{"id":1493347,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-04T20:11:12.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":12254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":12254,"derivative":{"exercise_price":0,"exercise_date":"2025-06-01","underlying":"Common Stock","underlying_shares":12254},"source":{"system":"sec-edgar","filing":"0001077183-24-000097","document":"wk-form4_1717531862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000097/wk-form4_1717531862.xml","form_type":"4"}},{"id":1493346,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2024-06-04T20:11:12.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":8672,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8672,"derivative":{"exercise_price":13.71,"exercise_date":"2025-06-01","expiration_date":"2034-06-01","underlying":"Common Stock","underlying_shares":8672},"source":{"system":"sec-edgar","filing":"0001077183-24-000097","document":"wk-form4_1717531862.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718324000097/wk-form4_1717531862.xml","form_type":"4"}},{"id":1809015,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-08-14T21:42:01.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":11336,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Once vested, the shares of common stock are not subject to expiration."}],"balance_after":11336,"derivative":{"exercise_price":0,"exercise_date":"2024-08-10","underlying":"Common Stock","underlying_shares":11336},"source":{"system":"sec-edgar","filing":"0001077183-23-000122","document":"wk-form4_1692049312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000122/wk-form4_1692049312.xml","form_type":"4"}},{"id":1809014,"issuer":{"id":2096,"kind":"organization","name":"NEOGENOMICS INC","symbol":"NEO"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (Right to Buy)","published_at":"2023-08-14T21:42:01.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":8353,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8353,"derivative":{"exercise_price":14.82,"exercise_date":"2024-08-10","expiration_date":"2033-08-10","underlying":"Common Stock","underlying_shares":8353},"source":{"system":"sec-edgar","filing":"0001077183-23-000122","document":"wk-form4_1692049312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718323000122/wk-form4_1692049312.xml","form_type":"4"}},{"id":2290980,"issuer":{"id":1816,"kind":"organization","name":"Streamex Corp.","symbol":"STEX"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-25T21:22:57.000Z","date":"2021-12-28","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall be fully vested and exercisable as of December 28, 2021, the date of the grant, subject to the terms and conditions of the BioSig Technologies, Inc. 2012 Equity Incentive Plan and the stock option agreement by and between the Company and the reporting person."}],"balance_after":50000,"derivative":{"exercise_price":2.44,"expiration_date":"2031-12-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001185185-22-000499","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518522000499/ownership.xml","form_type":"4"}},{"id":3084794,"issuer":{"id":1816,"kind":"organization","name":"Streamex Corp.","symbol":"STEX"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-11T01:43:11.000Z","date":"2020-07-08","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001185185-20-000988","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1530766/000118518520000988/ownership.xml","form_type":"4"}},{"id":4250713,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-07-26T23:04:04.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":132500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 132,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 132,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 132,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Immediately prior to the Effective Time, the Reporting Person beneficially owned unexercised options to purchase 132,500 Ordinary Shares (the \"Options\").  Pursuant to the terms of the Transaction Agreement, immediately prior to the Effective Time, the Options were cancelled without any consideration being payable in respect thereof."}],"balance_after":0,"derivative":{"exercise_price":8.8,"expiration_date":"2026-03-30","underlying":"Ordinary Shares, par value $0.01 per share","underlying_shares":132500},"source":{"system":"sec-edgar","filing":"0001144204-17-038446","document":"v471497_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1582393/000114420417038446/v471497_4.xml","form_type":"4"}},{"id":4250712,"issuer":{"id":12261,"kind":"organization","name":"Innocoll Holdings plc","symbol":"INNL"},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Ordinary Shares, par value $0.01 per share","published_at":"2017-07-26T23:04:04.000Z","date":"2017-07-24","kind":"disposition_to_issuer","acquired":false,"shares":682396,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Immediately prior to the Effective Time (as defined below), the Reporting Person beneficially owned (i) 542,396 ordinary shares of the Issuer, par value $0.01 per share (\"Ordinary Shares\") , and (ii) 140,000 restricted stock units (\"RSUs\") issued under the Issuer's 2016 Omnibus Incentive Compensation Plan (the \"Plan\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the Transaction Agreement by and among the Issuer, Gurnet Point L.P., a Delaware limited partnership acting through its general partner Waypoint International GP LLC (\"Gurnet Point\"), and Lough Ree Technologies Limited, an Irish private limited company and wholly-owned subsidiary of Gurnet Point (the \"Transaction Agreement\"), each Ordinary Share that was beneficially owned by the Reporting Person immediately prior to the effective time of the scheme (the \"Effective Time\") now represents the right to receive (i) $1.75 in cash and (ii) a contingent value right which represents a contractual right to receive payments up to a maximum aggregate amount of $4.90 in cash upon, and subject to, the occurrence of certain events, without interest and net of applicable tax withholdings (the \"Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Transaction Agreement, each RSU that was beneficially owned by the Reporting Person immediately prior to the Effective Time, was cancelled and now represents the right to receive the Consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pursuant to the terms of the Transaction Agreement by and among the Issuer, Gurnet Point L.P., a Delaware limited partnership acting through its general partner Waypoint International GP LLC (\"Gurnet Point\"), and Lough Ree Technologies Limited, an Irish private limited company and wholly-owned subsidiary of Gurnet Point (the \"Transaction Agreement\"), each Ordinary Share that was beneficially owned by the Reporting Person immediately prior to the effective time of the scheme (the \"Effective Time\") now represents the right to receive (i) $1.75 in cash and (ii) a contingent value right which represents a contractual right to receive payments up to a maximum aggregate amount of $4.90 in cash upon, and subject to, the occurrence of certain events, without interest and net of applicable tax withholdings (the \"Consideration\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Pursuant to the terms of the Transaction Agreement, each RSU that was beneficially owned by the Reporting Person immediately prior to the Effective Time, was cancelled and now represents the right to receive the Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-17-038446","document":"v471497_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1582393/000114420417038446/v471497_4.xml","form_type":"4"}}]}